SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-20-124472
Filing Date
2020-04-29
Accepted
2020-04-29 07:30:40
Documents
6
Period of Report
2020-06-09
Effectiveness Date
2020-04-29

Document Format Files

Seq Description Document Type Size
1 DEF 14A d923408ddef14a.htm DEF 14A 577324
2 GRAPHIC g923408g00u26.jpg GRAPHIC 29827
3 GRAPHIC g923408g04h28.jpg GRAPHIC 99857
4 GRAPHIC g923408g79m00.jpg GRAPHIC 100354
5 GRAPHIC g923408pc1.jpg GRAPHIC 176884
6 GRAPHIC g923408pc2.jpg GRAPHIC 145747
  Complete submission text file 0001193125-20-124472.txt   1337003
Mailing Address 215 FIRST STREET CAMBRIDGE MA 02142
Business Address 215 FIRST STREET CAMBRIDGE MA 02142 617-299-8380
Sage Therapeutics, Inc. (Filer) CIK: 0001597553 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-36544 | Film No.: 20827390
SIC: 2834 Pharmaceutical Preparations